Mark Herrmann has details of Sinclair v. Merck. The decision also suggests that the New Jersey Supreme Court is going to affirm the intermediate McDarby decision rejecting the use of consumer-fraud law for product-liability claims in New Jersey.
Chronicling the high cost of our legal system
by Ted Frank on June 4, 2008
Mark Herrmann has details of Sinclair v. Merck. The decision also suggests that the New Jersey Supreme Court is going to affirm the intermediate McDarby decision rejecting the use of consumer-fraud law for product-liability claims in New Jersey.
Tagged as: class actions, medical monitoring, New Jersey, pharmaceuticals, Vioxx

Get your copy today! My new book tackles the question of why so many bad ideas come from the law schools. "Cutting-edge commentary, hard-hitting, witty, astute." -- Publisher's Weekly. "Excellent... A fine dissection of these strangely powerful institutions" -- Wall Street Journal.
Individual liberty, free markets, and peace: the world's premier libertarian think tank. Publishes Cato at Liberty, where I blog on contemporary policy issues.
Get smart with the Thesis WordPress Theme from DIY Themes.